15% off your order at United Lab Peptides: Visit unitedlabpeptides.com ↗
Longevity

Epitalon

Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on the natural pineal extract epithalamin that has shown telomerase-activating and antioxidant effects in cultured cells and animal studies, but human evidence remains limited to small, older studies from a single Russian research group that have not been independently replicated in rigorous Western clinical trials.

Research status: Primarily Russian-language preclinical and small clinical studies; limited independent replication.

This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.

Peptide profile

What it does & how it works

Epitalon is proposed to act inside the cell nucleus as a gene-expression regulator ('bioregulator') rather than through a classical membrane receptor. In vitro work in telomerase-deficient human fetal fibroblasts reported that Epitalon activated expression of the telomerase catalytic subunit (hTERT), increased telomerase enzymatic activity, and elongated telomeres. It is also hypothesized to modulate pineal melatonin synthesis and to reduce lipid peroxidation, though the precise molecular target and human dose-response relationship have not been established.

Typical results seen in research

In cultured human somatic cells, Epitalon treatment increased telomerase activity and telomere length, and in various animal models it has been associated with reduced markers of age-related pathology and altered melatonin/circadian rhythms. Human data come almost entirely from a small number of studies by one research group using older or methodologically limited designs; there is no independently replicated, peer-reviewed evidence that Epitalon lengthens telomeres, extends lifespan, or improves aging biomarkers in people.

How it’s commonly used

In research settings Epitalon has been administered by subcutaneous or intramuscular injection, typically in short, cyclical courses rather than continuously. It has no FDA-approved indication and no clinical protocol validated outside the original research program that developed it.

Selected references

Curated from published literature for research orientation. Not an exhaustive review, and not a substitute for reading primary sources.

Epitalon in the news

See all peptide news →

Related in Longevity

← Compare vendor pricing on the Deals page

15% off your order at United Lab Peptides: Visit unitedlabpeptides.com ↗